FDA inspection

SGS United Kingdom Limited: FDA inspection ending Jul 20, 2023

FDA inspection 1260002 · Voluntary Action Indicated (VAI) · Deeside

Key facts

Inspection ID 1260002
Firm SGS United Kingdom Limited
FEI number 3009530711
Address Quay House, 28 Parkway
City Deeside
Country United Kingdom
Fiscal year 2023
Inspection end date Jul 20, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections